Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2019 | Percentile | Sector n |
|---|---|---|---|---|
| Iris Borchashvili Healt… | Healthcare Services | 14.4% | 50th pct | 241 |
| Tbilisis Zghvis Hospita… | Healthcare Services | 11.8% | 42nd pct | 241 |
| Qel-Qur-Tskhviris Sneul… | Healthcare Services | 11.6% | 41st pct | 241 |
| Rukhi Republican Hospit… | Healthcare Services | — | no FY data | 241 |
| Pirveli Saavadmqopo | Healthcare Services | — | no FY data | 241 |
Percentile is within each company's own sector across the whole FY2019 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
| Ratio — FY 2019 | Iris Borchashvili Healt… | Qel-Qur-Tskhviris Sneul… | Tbilisis Zghvis Hospita… | Rukhi Republican Hospit… | Pirveli Saavadmqopo |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 27.4% | 91.3% | 78.2% | — | N/A |
| EBITDA Margin | 14.4% | 11.6% | 11.8% | — | N/A |
| EBITDAR | 2,041 | 1,039 | 1,100 | — | -18 |
| EBITDAR Margin | 14.4% | 11.6% | 14.4% | — | N/A |
| EBIT Margin | 14.4% | 10.2% | 3.4% | — | N/A |
| Net Profit Margin | 14.3% | 10.2% | -4.6% | — | N/A |
| Operating Expense % of Sales | 13.0% | 79.6% | 66.4% | — | N/A |
| Returns | |||||
| Return on Assets (ROA) | 7.4% | 36.9% | -5.2% | — | -0.5% |
| Return on Equity (ROE) | 10.4% | 75.0% | N/A | — | -3.6% |
| ROIC [EBIT / Invested Capital] | 10.2% | 76.9% | N/A | — | -3.0% |
| Leverage & debt balances | |||||
| Debt-to-Assets | 3.0% | 0.0% | 45.4% | — | 3.6% |
| Debt-to-Equity | 0.04x | 0.00x | -0.58x | — | 0.25x |
| Debt-to-EBITDA | 0.40x | 0.00x | 3.36x | — | N/A |
| Equity-to-Assets | 71.7% | 49.2% | -78.2% | — | 14.7% |
| Net Debt | 515 | -29 | 3,008 | — | 88 |
| Cash & Equivalents | 304 | 29 | 23 | — | 37 |
| Total Debt | 819 | N/A | 3,030 | — | 125 |
| Liquidity & working capital | |||||
| Current Ratio | 0.83x | 2.23x | 0.62x | — | 1.28x |
| Quick Ratio | 0.71x | 2.04x | 0.59x | — | 1.28x |
| Cash Ratio | 0.04x | 0.03x | 0.00x | — | 0.10x |
| Total Current Assets | 5,890 | 1,942 | 5,011 | — | 477 |
| Total Current Liabilities | 7,089 | 871 | 8,055 | — | 373 |
| Inventory | 851 | 169 | 224 | — | N/A |
| Trade Receivables | 4,204 | 1,744 | 4,708 | — | N/A |
| Trade Payables | 6,882 | 348 | 3,244 | — | 352 |
| Net Working Capital | -1,199 | 1,072 | -3,044 | — | 104 |
| Net Working Capital % of Revenue | -8.4% | 12.0% | -40.0% | — | N/A |
| Trade Working Capital | -1,827 | 1,565 | 1,688 | — | -352 |
| Trade Working Capital % of Revenue | -12.9% | 17.5% | 22.2% | — | N/A |
| Change in Trade Working Capital | N/A | N/A | N/A | — | N/A |
| Turnover & efficiency | |||||
| Inventory Turnover | 12.11x | 4.60x | 7.40x | — | N/A |
| Days Inventory Outstanding (DIO) | 30.1 | 79.3 | 49.4 | — | N/A |
| Receivables Turnover | 3.38x | 5.12x | 1.62x | — | N/A |
| Days Sales Outstanding (DSO) | 108.1 | 71.4 | 225.5 | — | N/A |
| Payables Turnover | 1.50x | 2.24x | 0.51x | — | N/A |
| Days Payable Outstanding (DPO) | 243.8 | 163.2 | 713.5 | — | N/A |
| Cash Conversion Cycle | -105.5 days | -12.5 days | -438.6 days | — | N/A |
| Asset Turnover | 0.52x | 3.61x | 1.14x | — | 0.00x |
| Cash flow & dividends | |||||
| Operating Cash Flow | 6,146 | 540 | -134 | — | N/A |
| Free Cash Flow (OCF − Capex proxy) | 1,453 | 440 | -367 | — | N/A |
| Cash Conversion (OCF / EBITDA) | 301.1% | 52.0% | -14.9% | — | N/A |
| Dividends Declared | 0 | N/A | N/A | — | N/A |
| Dividend Payout Ratio | 0.0% | N/A | N/A | — | N/A |